Skip to Content

Church & Dwight Earnings: Despite Modest Volume Gains, Competitive and Macro Angst Loom Large

Consumer Defensive Sector artwork

We don’t expect any change to our $61 fair value estimate (beyond time value) after dissecting no-moat Church & Dwight’s CHD third-quarter print, which included 4.8% organic sales growth. This was the first quarter of the last eight Church was able to eek out volume growth—to the tune of 2.7%, even as prices rose 2.1%—which could suggest its mix is winning with a cash-constrained consumer (as 40% of its portfolio is made up of value offerings). However, our enthusiasm is tempered as it was lapping dismal year-ago results, which included an 8.5% downdraft in volumes, as consumers turned their backs on Church’s more discretionary product lineup (WaterPik, VitaFusion, and Flawless).

As such, we aren’t wavering on our stance that against an intensifying competitive backdrop, Church could be left out in the cold. From our vantage point, its category exposure leaves it open to consumers trading down to lower-priced fare and/or avoiding its mix all together until their financial condition improves. Its standing is further compromised as it lacks the scale, resources, and negotiating prowess of its larger brethren (wide-moats Procter & Gamble, Colgate, and Unilever). Even as shares slipped around 7% on the news, the stock still trades at about a 40% premium to our intrinsic valuation; we think investors should leave Church & Dwight’s shares on the shelf.

From a profitability perspective, the firm realized 270 basis points of expansion at the gross margin line to 44.4%, though this lags the 45% marks that used to characterize the business prior to the pandemic. While we surmise that inflation will remain a headwind over the next several quarters (particularly as oil, resin, and labor costs have yet to abate), we don’t expect Church will opt for further price hikes, which could alienate penny-pinching consumers. Rather, we suspect the firm will favor scouring the business to unearth inefficiencies, which we see as prudent when married with continued brand investments.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Erin Lash

Sector Director
More from Author

Erin Lash, CFA, is director of consumer sector equity research for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. In addition to leading the sector team, Lash covers packaged food and household and personal care companies.

Before joining Morningstar in 2006, she spent four years as an investment analyst covering retail, transportation, and technology firms for State Farm Insurance.

Lash holds a bachelor’s degree in finance from Bradley University and a master’s degree in business administration, with concentrations in accounting and finance, from the University of Chicago Booth School of Business. She also holds the Chartered Financial Analyst® designation. She ranked second in the food and tobacco industry in The Wall Street Journal’s annual “Best on the Street” analysts survey in 2013, the last year the survey was conducted.

Sponsor Center